Are there copyright issues with biorender materials?

The primary copyright issues with BioRender materials stem from the platform's specific licensing structure, which is more restrictive than open-source or public domain resources. BioRender grants users a non-exclusive, non-transferable, revocable license to use its proprietary icons and templates solely within the BioRender web application and for the purposes of creating scientific figures. The critical legal boundary is that the raw icon files themselves—the individual graphical assets—remain the intellectual property of BioRender and cannot be extracted, redistributed, or used independently outside the platform. This means a user cannot legally download an icon as a standalone SVG file and incorporate it into a different software like Adobe Illustrator or a presentation template for broader use. Violations typically occur when users attempt to bypass the platform's export controls or use the graphical elements in a manner explicitly prohibited by the Terms of Service, such as for commercial merchandising or as part of a competing graphic asset library.

The mechanism for compliant use is tightly integrated into BioRender's export functions. When a user exports a complete figure as a PDF, PNG, or JPEG, the license permits the incorporation of the rendered icons into scientific posters, publication manuscripts, slide presentations, and grant applications. This use is generally covered under the standard subscription, provided the final output is a flattened image file where the individual assets are not separable or reusable. The distinction between using a composed figure and extracting individual elements is the core of the copyright policy. For commercial uses, such as in textbooks, commercial websites, or product marketing, explicit written permission from BioRender and potentially an additional license is required, as the standard academic or individual subscriptions do not cover broad commercial redistribution.

Implications for users are significant, particularly in collaborative and commercial research environments. Academic researchers sharing figure source files must ensure collaborators are using BioRender legitimately, as sharing a `.bio` project file could enable unauthorized reuse of the proprietary icons. Institutions and corporations must secure appropriate enterprise licenses that define permitted user counts and commercial application scopes to avoid infringement. The onus is on the user to understand that they are licensing a service to create figures, not purchasing the underlying graphic assets. Compared to using self-created illustrations or truly open-source clipart, BioRender offers efficiency and standardization at the cost of ongoing subscription dependency and limited portability.

Ultimately, avoiding copyright issues with BioRender materials requires strict adherence to its export protocols and intended use cases. Users must refrain from any technical workaround to isolate icons and should proactively seek clarification from BioRender for any use case beyond direct inclusion in scientific communication for non-commercial purposes. The platform's legal framework is designed to protect its curated library as a core business asset, making compliance a matter of operational discipline rather than creative interpretation.